Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations

Understanding the risks of COVID-19 in patients with Multiple Sclerosis (MS) receiving disease-modifying therapies (DMTs) and their immune reactions is vital to analyze vaccine response dynamics. A systematic review on COVID-19 course and outcomes in patients receiving different DMTs was conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabreira, Verónica, Abreu, Pedro, Soares-dos-Reis, Ricardo, Guimarães, Joana, Sá, Maria José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310076/
https://www.ncbi.nlm.nih.gov/pubmed/34358189
http://dx.doi.org/10.3390/vaccines9070773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310076/
https://www.ncbi.nlm.nih.gov/pubmed/34358189
http://dx.doi.org/10.3390/vaccines9070773

Ejemplares similares